Pulmonary Hypertension in Hsct

Pulmonary Hypertension in Hsct Publisher

Mirtajaddini M¹ ; Sahebjam M² ; Esfandbod M³ ; Shahi F⁴ ; Mohseni M⁵

Show Affiliations

1. Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran
2. Department of Clinical Pharmacy, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3. Department of Hematology and Oncology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
4. Department of Hematology and Medical Oncology, Cancer Research Center, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
5. Cardio-Oncology Research Center, Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran

Source: Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation Published:2024

Abstract

Pulmonary hypertension (PH) is one of the important complications after hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation (HSCT) (HSCT). PH after HSCT can occur with different causes and mechanisms. Increased pulmonary vascular resistance Pulmonary vascular resistance can cause PH, which can lead to right ventricular failure Right ventricular failure. In this chapter, we discuss the causes of PH, its classification and how to diagnose and treat it in patients after HSCT. © Springer Nature Switzerland AG 2024. All rights reserved.

Style	Citing Format
MLA	Mirtajaddini M, et al.. "Pulmonary Hypertension in Hsct." Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, vol. , no. , 2024, pp. 201-210.
APA	Mirtajaddini M, Sahebjam M, Esfandbod M, Shahi F, Mohseni M (2024). Pulmonary Hypertension in Hsct. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, (), 201-210.
Chicago	Mirtajaddini M, Sahebjam M, Esfandbod M, Shahi F, Mohseni M. "Pulmonary Hypertension in Hsct." Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation , no. (2024): 201-210.
Harvard	Mirtajaddini M et al. (2024) 'Pulmonary Hypertension in Hsct', Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation, (), pp. 201-210.
Vancouver	Mirtajaddini M, Sahebjam M, Esfandbod M, Shahi F, Mohseni M. Pulmonary Hypertension in Hsct. Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation. 2024;():201-210.
BibTex	@article{ author = {Mirtajaddini M and Sahebjam M and Esfandbod M and Shahi F and Mohseni M}, title = {Pulmonary Hypertension in Hsct}, journal = {Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation}, volume = {}, number = {}, pages = {201-210}, year = {2024} }
RIS	TY - JOUR AU - Mirtajaddini M AU - Sahebjam M AU - Esfandbod M AU - Shahi F AU - Mohseni M TI - Pulmonary Hypertension in Hsct JO - Cardiovascular Considerations in Hematopoietic Stem Cell Transplantation VL - IS - SP - 201 EP - 210 PY - 2024 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract